(Reuters) – Futures tracking the S&P 500 and the Dow rose on Monday after Moderna Inc <MRNA.O> said its experimental vaccine was 94.5% effective in preventing COVID-19, a week after Pfizer Inc <PFE.N> reported positive results from its own late-stage trial.
At 7:00 a.m. ET, Dow e-minis <1YMcv1> were up 488 points, or 1.66%, and S&P 500 e-minis <EScv1> were up 39.5 points, or 1.1%. Nasdaq 100 e-minis <NQcv1> erased early gains to trade down 5.5 points, or 0.05%.
(Reporting by Sagarika Jaisinghani in Bengaluru; Editing by Shounak Dasgupta)
The post S&P, Dow futures rise as Moderna says vaccine 94.5% effective appeared first on Morningology.
